OSIRIS THERAPEUTICS, INC. (OSIR) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 145 transactions totaling $37.9M, demonstrating a bullish sentiment with $29.5M in net insider flow. The most recent transaction on Apr 17, 2019 involved a transaction of 9,375 shares valued at $178.1K.
No significant insider buying has been recorded for OSIR in the recent period.
No significant insider selling has been recorded for OSIR in the recent period.
Based on recent SEC filings, insider sentiment for OSIR is bullish with an Insider Alignment Score of 89/100 and a net flow of $29.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at OSIRIS THERAPEUTICS, INC. (OSIR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading OSIR stock, having executed 145 transactions in the past 90 days. The most active insider is Peter Friedli (Executive), who has made 26 transactions totaling $333.5M.
Get notified when executives and directors at OSIR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 17, 2019 | Danilkovitch Alla | Executive | Disposition | 9,375 | $19.00 | $178.1K | |
| Apr 17, 2019 | Keefer Jason | Executive | Disposition | 4,000 | $19.00 | $76.0K | |
| Apr 17, 2019 | Friedli Peter | Executive | Disposition | 2,750 | $19.00 | $52.3K | |
| Apr 17, 2019 | Friedli Peter | Executive | Disposition | 4,103,301 | $19.00 | $78.0M | Large |
| Apr 17, 2019 | Friedli Peter | Executive | Disposition | 500,000 | $19.00 | $9.5M | Large |
| Apr 17, 2019 | Friedli Peter | Executive | Disposition | 10,204,404 | $19.00 | $193.9M | Large |
| Jul 24, 2018 | Venturetec Inc | Executive | Other | 3,000,000 | $N/A | $0 | |
| Jul 5, 2018 | Venturetec Inc | Executive | Other | 1,103,301 | $N/A | $0 | |
| Jan 25, 2017 | A. Dresner David | Executive | Option Exercise | 5,000 | $5.12 | $25.6K | |
| Jan 25, 2017 | A. Dresner David | Executive | Option Exercise | 5,000 | $5.30 | $26.5K | |
| Jan 25, 2017 | A. Dresner David | Executive | Option Exercise | 5,000 | $5.48 | $27.4K | |
| Jan 23, 2017 | A. Dresner David | Executive | Option Exercise | 5,000 | $5.03 | $25.1K | |
| Jan 12, 2017 | A. Dresner David | Executive | Option Exercise | 5,000 | $4.75 | $23.8K | |
| Nov 20, 2015 | Debrabandere Lode | Executive | Option Exercise | 37,500 | $6.84 | $256.5K | |
| Nov 19, 2015 | Danilkovitch Alla | Executive | Option Exercise | 4,000 | $5.08 | $20.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 6 | $281.7M | 80.9% |
Purchase(P) | 12 | $33.7M | 9.7% |
Exercise(M) | 63 | $13.2M | 3.8% |
Payment(F) | 1 | $11.0M | 3.2% |
Sale(S) | 18 | $4.2M | 1.2% |
Gift(G) | 10 | $2.9M | 0.8% |
Award(A) | 27 | $1.6M | 0.5% |
Other(J) | 8 | $0 | 0.0% |
Insiders at OSIRIS THERAPEUTICS, INC. are accumulating shares at an accelerated pace. With 18 insiders making 145 transactions totaling $33.7M in purchases versus $4.2M in sales, the net buying activity of $29.5M signals strong executive confidence. Peter Friedli (Executive) leads the buying activity with $333.5M in transactions across all time.